Elagolix, an oral gonadotropin-releasing hormone antagonist, for the management of endometriosis-associated pain: safety and efficacy results from two double-blind, randomized, placebo-controlled studies

Hugh S. Taylor, Linda C. Giudice, Bruce A. Lessey, Maurício Simões Abrão, Jan Kotarski, Laura Williams, J.P. Rowan, Kristof Chwalisż, W. Rachel Duan, Brittany Schwefel, James W. Thomas, Rinku Jain
In: Fertility and Sterility · 2016 · vol. 106(3) , pp. e271 · doi:10.1016/j.fertnstert.2016.07.780 · W2512641051
article OA: closed CC0 ⤵ 4 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This study evaluated the safety and efficacy of elagolix, an oral GnRH antagonist, for endometriosis-associated pain, reporting its findings from two double-blind, randomized, placebo-controlled trials.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (4)

Cited by (4)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK